Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016 (2016), Article ID 4389802, 8 pages
http://dx.doi.org/10.1155/2016/4389802
Review Article

The Aryl Hydrocarbon Receptor Relays Metabolic Signals to Promote Cellular Regeneration

Laboratorio de Investigación en Ciencias Ómicas y Biotecnología Aplicada, Pontificia Universidad Católica del Perú, Avenida Universitaria 1801, San Miguel, Lima 12, Peru

Received 28 January 2016; Revised 16 June 2016; Accepted 5 July 2016

Academic Editor: Andrzej Lange

Copyright © 2016 Fanny L. Casado. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Mason and P. Dunnill, “A brief definition of regenerative medicine,” Regenerative Medicine, vol. 3, no. 1, pp. 1–5, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. D. Yoo and Y. T. Kwon, “Molecular mechanisms controlling asymmetric and symmetric self-renewal of cancer stem cells,” Journal of Analytical Science and Technology, vol. 6, article 28, 2015. View at Publisher · View at Google Scholar
  3. J. M. Perry and L. Li, “Functional assays for hematopoietic stem cell self-renewal,” Methods in Molecular Biology, vol. 636, pp. 45–54, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. R. E. Ploemacher, J. C. M. Van Der Loo, J. P. Van Der Sluijs et al., “In vitro assays for primitive hematopoietic cells,” Blood, vol. 79, no. 3, pp. 834–836, 1992. View at Google Scholar · View at Scopus
  5. C. Taswell, “Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis,” The Journal of Immunology, vol. 126, no. 4, pp. 1614–1619, 1981. View at Google Scholar · View at Scopus
  6. A. Wodarz, “Molecular control of cell polarity and asymmetric cell division in Drosophila neuroblasts,” Current Opinion in Cell Biology, vol. 17, no. 5, pp. 475–481, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. J. A. Knoblich, “Mechanisms of asymmetric stem cell division,” Cell, vol. 132, no. 4, pp. 583–597, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Wohrer, D. J. H. F. Knapp, M. R. Copley et al., “Distinct stromal cell factor combinations can separately control hematopoietic stem cell survival, proliferation, and self-renewal,” Cell Reports, vol. 7, no. 6, pp. 1956–1967, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. M. S. Denison and L. M. Vella, “The hepatic Ah receptor for 2,3,7,8-Tetrachlorodibenzo-p-dioxin: species differences in subunit dissociation,” Archives of Biochemistry and Biophysics, vol. 277, no. 2, pp. 382–388, 1990. View at Publisher · View at Google Scholar · View at Scopus
  10. M. S. Denison, A. A. Soshilov, G. He, D. E. DeGroot, and B. Zhao, “Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor,” Toxicological Sciences, vol. 124, no. 1, pp. 1–22, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Fraccalvieri, A. A. Soshilov, S. I. Karchner et al., “Comparative analysis of homology models of the Ah receptor ligand binding domain: verification of structure-function predictions by site-directed mutagenesis of a nonfunctional receptor,” Biochemistry, vol. 52, no. 4, pp. 714–725, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Dietrich and B. Kaina, “The aryl hydrocarbon receptor (AhR) in the regulation of cell-cell contact and tumor growth,” Carcinogenesis, vol. 31, no. 8, pp. 1319–1328, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. K. P. Singh, A. Wyman, F. L. Casado, R. W. Garrett, and T. A. Gasiewicz, “Treatment of mice with the Ah receptor agonist and human carcinogen dioxin results in altered numbers and function of hematopoietic stem cells,” Carcinogenesis, vol. 30, no. 1, pp. 11–19, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. D. Laiosa, E. R. Tate, L. S. Ahrenhoerster, Y. Chen, and D. Wang, “Effects of developmental activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin on long-term self-renewal of murine hematopoietic stem cells,” Environmental Health Perspectives, 2015. View at Publisher · View at Google Scholar
  15. J. van Grevenynghe, M. Bernard, S. Langouet, C. Le Berre, T. Fest, and O. Fardel, “Human CD34-positive hematopoietic stem cells constitute targets for carcinogenic polycyclic aromatic hydrocarbons,” Journal of Pharmacology and Experimental Therapeutics, vol. 314, no. 2, pp. 693–702, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. A. E. Boitano, J. Wang, R. Romeo et al., “Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells,” Science, vol. 329, no. 5997, pp. 1345–1348, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. K. J. Smith, I. A. Murray, R. Tanos et al., “Identification of a high-affinity ligand that exhibits complete aryl hydrocarbon receptor antagonism,” Journal of Pharmacology and Experimental Therapeutics, vol. 338, no. 1, pp. 318–327, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. F. L. Casado, K. R. Salci, Z. Shapovalova, B. Guezguez, T. J. Collins, and M. Bhatia, “Expansion of primary human AML by aryl hydrocarbon receptor antagonism minimally affects leukemic transcriptional profiles but alters cellular metabolism,” Journal of Hematology Research, vol. 2, pp. 9–16, 2016. View at Publisher · View at Google Scholar
  19. S. Rentas, N. T. Holzapfel, M. S. Belew et al., “Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells,” Nature, vol. 532, no. 7600, pp. 508–511, 2016. View at Publisher · View at Google Scholar
  20. J. Amiel-Pérez and F. Casado, “Stem cells: limitations and opportunities in Peru,” Revista Peruana de Medicina Experimental y Salud Publica, vol. 32, no. 4, pp. 777–786, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. J.-H. Lee, R. R. Mitchell, J. D. McNicol et al., “Single transcription factor conversion of human blood fate to NPCs with CNS and PNS developmental capacity,” Cell Reports, vol. 11, no. 9, pp. 1367–1376, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. A. A. Cardoso, M.-L. Li, P. Batard et al., “Release from quiescence of CD34+ CD38- human umbilical cord blood cells reveals their potentiality to engraft adults,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 18, pp. 8707–8711, 1993. View at Publisher · View at Google Scholar · View at Scopus
  23. D. J. Pearce, D. Taussig, K. Zibara et al., “AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML,” Blood, vol. 107, no. 3, pp. 1166–1173, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Cicalese, G. Bonizzi, C. E. Pasi et al., “The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells,” Cell, vol. 138, no. 6, pp. 1083–1095, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Dubrovska, A. Hartung, L. C. Bouchez et al., “CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling,” British Journal of Cancer, vol. 107, no. 1, pp. 43–52, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. H. Maayah, H. Ghebeh, A. A. Alhaider et al., “Metformin inhibits 7,12-dimethylbenz[a]anthracene-induced breast carcinogenesis and adduct formation in human breast cells by inhibiting the cytochrome P4501A1/aryl hydrocarbon receptor signaling pathway,” Toxicology and Applied Pharmacology, vol. 284, no. 2, pp. 217–226, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. K. W. Bock, “Toward elucidation of dioxin-mediated chloracne and Ah receptor functions,” Biochemical Pharmacology, vol. 112, pp. 1–5, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Faust, S. Kletting, E. Ueberham, and C. Dietrich, “Aryl hydrocarbon receptor-dependent cell cycle arrest in isolated mouse oval cells,” Toxicology Letters, vol. 223, no. 1, pp. 73–80, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Blum, R. Gupta, P. E. Burger et al., “Molecular signatures of prostate stem cells reveal novel signaling pathways and provide insights into prostate cancer,” PLoS ONE, vol. 4, no. 5, Article ID e5722, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. L. S. Ahrenhoerster, T. C. Leuthner, E. R. Tate, P. A. Lakatos, and M. D. Laiosa, “Developmental exposure to 2,3,7,8 tetrachlorodibenzo-p-dioxin attenuates later-life Notch1-mediated T cell development and leukemogenesis,” Toxicology and Applied Pharmacology, vol. 283, no. 2, pp. 99–108, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. J. S. Lee, M. Cella, K. G. McDonald et al., “AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch,” Nature Immunology, vol. 13, no. 2, pp. 144–152, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. Q. Wang, H. Kurita, V. Carreira et al., “Ah receptor activation by dioxin disrupts activin, BMP, and WNT signals during the early differentiation of mouse embryonic stem cells and inhibits cardiomyocyte functions,” Toxicological Sciences, vol. 149, no. 2, pp. 346–357, 2016. View at Publisher · View at Google Scholar
  33. E. A. Thackaberry, E. J. Bedrick, M. B. Goens et al., “Insulin regulation in AhR-null mice: embryonic cardiac enlargement, neonatal macrosomia, and altered insulin regulation and response in pregnant and aging AhR-null females,” Toxicological Sciences, vol. 76, no. 2, pp. 407–417, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. K. P. Singh, J. A. Bennett, F. L. Casado, J. L. Walrath, S. L. Welle, and T. A. Gasiewicz, “Loss of aryl hydrocarbon receptor promotes gene changes associated with premature hematopoietic stem cell exhaustion and development of a myeloproliferative disorder in aging mice,” Stem Cells and Development, vol. 23, no. 2, pp. 95–106, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Tang, K. Chen, F. Yang, and W. Liu, “Exposure to organochlorine pollutants and type 2 diabetes: a systematic review and meta-analysis,” PLoS ONE, vol. 9, no. 10, article e85556, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. D.-H. Lee, P. M. Lind, D. R. Jacobs Jr., S. Salihovic, B. van Bavel, and L. Lind, “Polychlorinated biphenyls and organochlorine pesticides in plasma predict development of type 2 diabetes in the elderly: the prospective investigation of the vasculature in Uppsala Seniors (PIVUS) study,” Diabetes Care, vol. 34, no. 8, pp. 1778–1784, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. J. E. Gunton, R. N. Kulkarni, S. Yim et al., “Loss of ARNT/HIF1β mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes,” Cell, vol. 122, no. 3, pp. 337–349, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. T. B. Salisbury, J. K. Tomblin, D. A. Primerano et al., “Endogenous aryl hydrocarbon receptor promotes basal and inducible expression of tumor necrosis factor target genes in MCF-7 cancer cells,” Biochemical Pharmacology, vol. 91, no. 3, pp. 390–399, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. A. M. Fernández, J. K. Kim, S. Yakar et al., “Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes,” Genes and Development, vol. 15, no. 15, pp. 1926–1934, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Dabir, T. E. Marinic, I. Krukovets, and O. I. Stenina, “Aryl Hydrocarbon receptor is activated by glucose and regulates the thrombospondin-1 gene promoter in endothelial cells,” Circulation Research, vol. 102, no. 12, pp. 1558–1565, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. V. Sun, D. R. Boverhof, L. D. Burgoon, M. R. Fielden, and T. R. Zacharewski, “Comparative analysis of dioxin response elements in human, mouse and rat genomic sequences,” Nucleic Acids Research, vol. 32, no. 15, pp. 4512–4523, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Kamata, K.-I. Katsube, M. Michikawa, M. Yamada, S. Takada, and H. Mizusawa, “R-spondin, a novel gene with thrombospondin type 1 domain, was expressed in the dorsal neural tube and affected in Wnts mutants,” Biochimica et Biophysica Acta—Gene Structure and Expression, vol. 1676, no. 1, pp. 51–62, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. M. L. Warner, T. Bell, and A. A. Pioszak, “Engineering high-potency R-spondin adult stem cell growth factors,” Molecular Pharmacology, vol. 87, no. 3, pp. 410–420, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Clevers, K. M. Loh, and R. Nusse, “An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control,” Science, vol. 346, no. 6205, Article ID 1248012, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. L. K. Mathew, M. T. Simonich, and R. L. Tanguay, “AHR-dependent misregulation of Wnt signaling disrupts tissue regeneration,” Biochemical Pharmacology, vol. 77, no. 4, pp. 498–507, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. J. K. Sethi and A. Vidal-Puig, “Wnt signalling and the control of cellular metabolism,” Biochemical Journal, vol. 427, no. 1, pp. 1–17, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. S. H. Anagnostou and P. R. Shepherd, “Glucose induces an autocrine activation of the Wnt/β-catenin pathway in macrophage cell lines,” Biochemical Journal, vol. 416, no. 2, pp. 211–218, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Chocarro-Calvo, J. M. García-Martínez, S. Ardila-González, A. De la Vieja, and C. García-Jiménez, “Glucose-induced β-catenin acetylation enhances Wnt signaling in cancer,” Molecular Cell, vol. 49, no. 3, pp. 474–486, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. P. Chafey, L. Finzi, R. Boisgard et al., “Proteomic analysis of β-catenin activation in mouse liver by DIGE analysis identifies glucose metabolism as a new target of the Wnt pathway,” Proteomics, vol. 9, no. 15, pp. 3889–3900, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. C. A. Opitz, U. M. Litzenburger, F. Sahm et al., “An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor,” Nature, vol. 478, no. 7368, pp. 197–203, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. H. Zhou and J. Skolnick, “FINDSITEcomb: a threading/structure-based, proteomic-scale virtual ligand screening approach,” Journal of Chemical Information and Modeling, vol. 53, no. 1, pp. 230–240, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. M. T. Mizwicki, D. Keidel, C. M. Bula et al., “Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1α,25(OH)2-vitamin D3 signaling,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 35, pp. 12876–12881, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. C. J. Baglole, S. B. Maggirwar, T. A. Gasiewicz, T. H. Thatcher, R. P. Phipps, and P. J. Sime, “The aryl hydrocarbon receptor attenuates tobacco smoke-induced cyclooxygenase-2 and prostaglandin production in lung fibroblasts through regulation of the NF-κB family member RelB,” The Journal of Biological Chemistry, vol. 283, no. 43, pp. 28944–28957, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. K. Omurtag, P. Esakky, B. J. Debosch, E. L. Schoeller, M. M. Chi, and K. H. Moley, “Modeling the effect of cigarette smoke on hexose utilization in spermatocytes,” Reproductive Sciences, vol. 22, no. 1, pp. 94–101, 2015. View at Publisher · View at Google Scholar · View at Scopus
  55. W.-H. Park, D. W. Jun, J. T. Kim et al., “Novel cell-based assay reveals associations of circulating serum AhR-ligands with metabolic syndrome and mitochondrial dysfunction,” Biofactors, vol. 39, no. 4, pp. 494–504, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Škrtić, S. Sriskanthadevan, B. Jhas et al., “Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia,” Cancer Cell, vol. 20, no. 5, pp. 674–688, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. M. J. Tisdale, “Cachexia in cancer patients,” Nature Reviews Cancer, vol. 2, no. 11, pp. 862–871, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. M. G. V. Heiden, L. C. Cantley, and C. B. Thompson, “Understanding the Warburg effect: the metabolic requirements of cell proliferation,” Science, vol. 324, no. 5930, pp. 1029–1033, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. I. Jansson, I. Stoilov, M. Sarfarazi, and J. B. Schenkman, “Effect of two mutations of human CYP1B1, G61e and R469W, on stability and endogenous steroid substrate metabolism,” Pharmacogenetics, vol. 11, no. 9, pp. 793–801, 2001. View at Publisher · View at Google Scholar · View at Scopus
  60. V. N. Silbiger, A. D. Luchessi, R. D. C. Hirata et al., “Novel genes detected by transcriptional profiling from whole-blood cells in patients with early onset of acute coronary syndrome,” Clinica Chimica Acta, vol. 421, pp. 184–190, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. E.-Y. Li, W.-Y. Huang, Y.-C. Chang et al., “Aryl hydrocarbon receptor activates NDRG1 transcription under hypoxia in breast cancer cells,” Scientific Reports, vol. 6, article 20808, 2016. View at Publisher · View at Google Scholar · View at Scopus
  62. T. Simsek, F. Kocabas, J. Zheng et al., “The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche,” Cell Stem Cell, vol. 7, no. 3, pp. 380–390, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. J. K. Manesia, Z. Xu, D. Broekaert et al., “Highly proliferative primitive fetal liver hematopoietic stem cells are fueled by oxidative metabolic pathways,” Stem Cell Research, vol. 15, no. 3, pp. 715–721, 2015. View at Publisher · View at Google Scholar · View at Scopus
  64. T. Tian, B. Chen, Y. Xiao, K. Yang, and X. Zhou, “Intramyocardial autologous bone marrow cell transplantation for ischemic heart disease: a systematic review and meta-analysis of randomized controlled trials,” Atherosclerosis, vol. 233, no. 2, pp. 485–492, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Rivas-Plata, J. Castillo, M. Pariona, and A. Chunga, “Bypass grafts and cell transplant in heart failure with low ejection fraction,” Asian Cardiovascular and Thoracic Annals, vol. 18, no. 5, pp. 425–429, 2010. View at Publisher · View at Google Scholar · View at Scopus